Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia

Cytogenetically normal acute myeloid leukemia (CN-AML) accounts for 40%–50% of all AML cases. Despite advances in understanding the molecular pathophysiology of CN-AML, its clinical outcome remains unsatisfactory and unpredictable. To investigate its clinical implication in CN-AML, we measured the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Young Eun, Lim, Ha Jin, Park, Ju Heon, Kim, Hye Ran, Kang, Min-Gu, Cho, Young Kuk, Shin, Jong Hee, Shin, Myung Geun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Laboratory Medicine 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057826/
https://www.ncbi.nlm.nih.gov/pubmed/35470276
http://dx.doi.org/10.3343/alm.2022.42.5.585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057826/
https://www.ncbi.nlm.nih.gov/pubmed/35470276
http://dx.doi.org/10.3343/alm.2022.42.5.585

Ejemplares similares